These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6369165)

  • 21. Interaction of the putative dopamine autoreceptor agonists 3-PPP and TL-99 with [3H]apomorphine binding sites in rat striatal membranes.
    Williams M; Totaro JA
    Eur J Pharmacol; 1982 Dec; 86(1):35-42. PubMed ID: 7160432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low doses of l-sulpiride down-regulate striatal and cortical dopamine receptors and beta-adrenoceptors.
    Sigala S; Rizzonelli P; Zanelli E; Forgione A; Missale C; Spano P
    Eur J Pharmacol; 1991 Jun; 199(2):247-53. PubMed ID: 1683290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sulpiride injection into the dorsal striatum increases methamphetamine-induced gnawing in rats.
    Koshikawa N; Aoki S; Tomiyama K; Maruyama Y; Kobayashi M
    Eur J Pharmacol; 1987 Jan; 133(1):119-25. PubMed ID: 3556388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopamine receptor binding: specificity, localization and regulation by ions and guanyl nucleotides.
    Creese I; Prosser T; Synder SH
    Life Sci; 1978 Aug; 23(5):495-9. PubMed ID: 692273
    [No Abstract]   [Full Text] [Related]  

  • 25. Dopamine receptor binding for agonists and antagonists in thermal exposed membranes.
    Lew JY; Goldstein M
    Eur J Pharmacol; 1979 May; 55(4):429-30. PubMed ID: 467499
    [No Abstract]   [Full Text] [Related]  

  • 26. Binding of [3H]sulpiride to purified rat striatal synaptic membranes.
    Woodruff GN; Freedman SB
    Neuroscience; 1981; 6(3):407-10. PubMed ID: 7219722
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on the action of (+/-)sulpiride on dopamine receptors in the rat brain in vivo.
    Hasan F; Leonard BE
    Neuropharmacology; 1981 Dec; 20(12B):1327-30. PubMed ID: 7198724
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of guanine nucleotides on dopaminergic agonist and antagonist affinity for [3H]sulpiride binding sites in rat striatal membrane preparations.
    Freedman SB; Poat JA; Woodruff GN
    J Neurochem; 1981 Sep; 37(3):608-12. PubMed ID: 7276943
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranes.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1987 Feb; 134(2):211-9. PubMed ID: 3569410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Further characterization of structural requirements for agonists at the striatal dopamine D-1 receptor. Studies with a series of monohydroxyaminotetralins on dopamine-sensitive adenylate cyclase and a comparison with dopamine receptor binding.
    Seiler MP; Markstein R
    Mol Pharmacol; 1982 Sep; 22(2):281-9. PubMed ID: 7144729
    [No Abstract]   [Full Text] [Related]  

  • 31. Similarities and dissimilarities between dopamine and neuroleptic receptors: further evidence for type 1 and type 2 dopamine receptors in the CNS.
    Spano PF; Memo M; Govoni S; Trabucchi M
    Adv Biochem Psychopharmacol; 1980; 24():113-21. PubMed ID: 6105769
    [No Abstract]   [Full Text] [Related]  

  • 32. A new dopaminergic prodrug.
    Horn AS; de Kaste D; Dijkstra D; Rollema H; Feenstra M; Westerink BH; Grol C; Westerbrink A
    Nature; 1978 Nov; 276(5686):405-7. PubMed ID: 714167
    [No Abstract]   [Full Text] [Related]  

  • 33. Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors.
    Yi SJ; Johnson KM
    Pharmacol Biochem Behav; 1990 Jul; 36(3):457-61. PubMed ID: 1974064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug effects on pre- and postsynaptic dopamine receptors.
    Andén NE; Grabowska-Andén M
    Adv Biochem Psychopharmacol; 1980; 24():57-64. PubMed ID: 6105802
    [No Abstract]   [Full Text] [Related]  

  • 35. Specific [3H]SCH23390 binding to dopamine D1 receptors in cerebral cortex and neostriatum: role of disulfide and sulfhydryl groups.
    Dewar KM; Reader TA
    J Neurochem; 1989 Feb; 52(2):472-82. PubMed ID: 2463335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 6-OHDA-induced lesion of the nigrostriatal dopaminergic neurons potentiates the inhibitory effect of 7-OHDPAT, a selective D3 agonist, on acetylcholine release during striatal microdialysis in conscious rats.
    Sato K; Ueda H; Okumura F; Misu Y
    Brain Res; 1994 Aug; 655(1-2):233-6. PubMed ID: 7812777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substituted benzamides as cerebral dopamine antagonists in rodents.
    Elliott PN; Jenner P; Huizing G; Marsden CD; Miller R
    Neuropharmacology; 1977 May; 16(5):333-42. PubMed ID: 559256
    [No Abstract]   [Full Text] [Related]  

  • 38. [Regulation of liberation and metabolism of dopamine in the dorsal striatum of free-living rats: the role of D2- and D3-dopamine autoreceptors].
    Gaĭnetdinov RR; Sotnikova TD; Grekhova TV; Raevskiĭ KS
    Dokl Akad Nauk; 1994 Aug; 337(6):821-3. PubMed ID: 7981645
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential visualization of dopamine D2 and D3 receptors in rat brain.
    Parsons B; Stanley M; Javitch J
    Eur J Pharmacol; 1993 Apr; 234(2-3):269-72. PubMed ID: 8097723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals.
    Westerink BH; de Vries JB
    Neurosci Lett; 1989 Apr; 99(1-2):197-202. PubMed ID: 2526308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.